Spots Global Cancer Trial Database for paraplatin
Every month we try and update this database with for paraplatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| MPDL3280A With Chemoradiation for Lung Cancer | NCT02525757 | Lung Cancer Non-Small Cell ... | MPDL3280A Carboplatin Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | NCT00539500 | Neuroblastoma | Carboplatin Etoposide Melphalan Stem Cell Infus... ClinicMACS | - | M.D. Anderson Cancer Center | |
| Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | NCT00502892 | Solid Tumors | Topotecan Ifosfamide Carboplatin | - 45 Years | M.D. Anderson Cancer Center | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | NCT00529022 | Solid Tumors | Azacitidine Valproic Acid Carboplatin | - | M.D. Anderson Cancer Center | |
| Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | NCT00439361 | Hodgkin Lymphom... Lymphoma | Bortezomib Carboplatin Etoposide Ifosfamide Mesna | 16 Years - | M.D. Anderson Cancer Center | |
| Treatment of Tumors of the Choroid Plexus Epithelium | NCT00500890 | Choroid Plexus ... | Carboplatin Cyclophosphamid... Etoposide Vincristine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | NCT00495170 | Lung Cancer | Carboplatin Proton Radiothe... Paclitaxel | - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer | NCT01263782 | Lung Cancer | Carboplatin Pemetrexed Bevacizumab Cixutumumab | 18 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | NCT00514540 | Prostate Cancer | Docetaxel Carboplatin Etoposide Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus | NCT00502203 | Mixed Tumor, Mu... | Carboplatin Paclitaxel | - | M.D. Anderson Cancer Center | |
| A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies | NCT01542047 | Cancer, Metasta... | Carboplatin Pazopanib | 18 Years - | New Mexico Cancer Care Alliance | |
| Phase I Study of TAS-106 in Combo With Carboplatin | NCT00752011 | Cancer Solid Tumors | TAS-106 Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) | NCT01562301 | Chemotherapeuti... Lung Cancer | Carboplatin Docetaxel Anvirzel Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV | NCT00231075 | Ovarian Cancer | Paraplatin Paclitaxel | 70 Years - | ARCAGY/ GINECO GROUP | |
| Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | NCT00514540 | Prostate Cancer | Docetaxel Carboplatin Etoposide Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
| Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer | NCT00429182 | Breast Cancer Metastatic Brea... Invasive Breast... | Carboplatin Cyclophosphamid... Thiotepa Stem Cell Trans... | 18 Years - 55 Years | M.D. Anderson Cancer Center | |
| Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) | NCT00388076 | Neoplasms, Brea... | Pazopanib Lapatinib paclitaxel carboplatin | 18 Years - | GlaxoSmithKline | |
| Phase I Study of TAS-106 in Combo With Carboplatin | NCT00752011 | Cancer Solid Tumors | TAS-106 Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
| BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) | NCT00533585 | Lung Cancer | BAY 43-9006 Paclitaxel Carboplatin Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma | NCT02106988 | Lymphoma | Radiation Thera... Dexamethasone Etoposide phosp... Ifosfamide Mesna Carboplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors | NCT00502892 | Solid Tumors | Topotecan Ifosfamide Carboplatin | - 45 Years | M.D. Anderson Cancer Center | |
| Study of Vemurafenib, Carboplatin, and Paclitaxel | NCT01636622 | Advanced Cancer... | Vemurafenib Carboplatin Paclitaxel | 12 Years - | M.D. Anderson Cancer Center | |
| Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) | NCT01562301 | Chemotherapeuti... Lung Cancer | Carboplatin Docetaxel Anvirzel Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer | NCT00059618 | Ovarian Cancer Primary Periton... Fallopian Tube ... | PS-341 (Bortezo... Carboplatin | - | M.D. Anderson Cancer Center | |
| High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | NCT00936936 | Testicular Canc... | Gemcitabine Docetaxel Melphalan Carboplatin Mesna Ifosfamide Etoposide Stem Cell Trans... | 12 Years - 65 Years | M.D. Anderson Cancer Center | |
| Treatment of Tumors of the Choroid Plexus Epithelium | NCT00500890 | Choroid Plexus ... | Carboplatin Cyclophosphamid... Etoposide Vincristine Radiation Thera... | - | M.D. Anderson Cancer Center | |
| Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | NCT02044601 | Lung Cancer | Onartuzumab Erlotinib Paclitaxel Carboplatin Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | NCT00501644 | Ovarian Cancer Fallopian Tube ... Peritoneal Canc... | Carboplatin GM-CSF (Sargram... Interferon Gamm... | - | M.D. Anderson Cancer Center | |
| Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | NCT00514540 | Prostate Cancer | Docetaxel Carboplatin Etoposide Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| Study of Vemurafenib, Carboplatin, and Paclitaxel | NCT01636622 | Advanced Cancer... | Vemurafenib Carboplatin Paclitaxel | 12 Years - | M.D. Anderson Cancer Center | |
| Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM) | NCT00555399 | Glioblastoma Mu... Anaplastic Glio... | Vorinostat Isotretinoin Surgical Resect... Temozolomide | 18 Years - | M.D. Anderson Cancer Center | |
| Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | NCT02044601 | Lung Cancer | Onartuzumab Erlotinib Paclitaxel Carboplatin Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) | NCT02044601 | Lung Cancer | Onartuzumab Erlotinib Paclitaxel Carboplatin Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) | NCT00563784 | Non-Small Cell ... Lung Cancer | Erlotinib Carboplatin Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer | NCT00059618 | Ovarian Cancer Primary Periton... Fallopian Tube ... | PS-341 (Bortezo... Carboplatin | - | M.D. Anderson Cancer Center | |
| Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | NCT00529022 | Solid Tumors | Azacitidine Valproic Acid Carboplatin | - | M.D. Anderson Cancer Center | |
| Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) | NCT01881230 | Breast Tumor Breast Cancer Cancer of the B... Estrogen Recept... HER2- Negative ... Progesterone Re... Recurrent Breas... Stage IV Breast... Triple-negative... Triple-negative... Metastatic Brea... | nab-Paclitaxel Carboplatin Gemcitabine | 18 Years - | Celgene | |
| Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | NCT00529022 | Solid Tumors | Azacitidine Valproic Acid Carboplatin | - | M.D. Anderson Cancer Center | |
| Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | NCT01036087 | Breast Cancer | Panitumumab Nab-paclitaxel Carboplatin 5-Fluorouracil Epirubicin Cyclophosphamid... | 18 Years - | M.D. Anderson Cancer Center | |
| MPDL3280A With Chemoradiation for Lung Cancer | NCT02525757 | Lung Cancer Non-Small Cell ... | MPDL3280A Carboplatin Paclitaxel Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
